Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesDividends payablesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bruker (BRKR) Curent Deferred Tax Liability (2010 - 2014)

Bruker posted quarterly Curent Deferred Tax Liability of $15.0 million for Q4 2014, down 10.18% year-on-year from $16.7 million in Q4 2013, and down 10.18% on a QoQ basis from $16.7 million in Q4 2013.

Bruker (BRKR) has 5 years of Curent Deferred Tax Liability data on file, last reported at $15.0 million in Q4 2014.

  • For the quarter ending Q4 2014, Curent Deferred Tax Liability fell 10.18% year-over-year to $15.0 million; the trailing twelve-month figure through Dec 2014 stood at $15.0 million (down 10.18% YoY), and the FY2014 full-year result was $15.0 million, down 10.18% from the prior year.
  • Curent Deferred Tax Liability for Q4 2014 stood at $15.0 million, down from $16.7 million in the prior quarter.
  • Across five years, Curent Deferred Tax Liability topped out at $16.7 million in Q4 2013 and bottomed at $6.9 million in Q4 2012.
  • The 5-year median for Curent Deferred Tax Liability is $11.2 million (2011), against an average of $11.8 million.
  • The widest annual swing landed in 2012, when Curent Deferred Tax Liability plunged 38.39%; it then jumped 142.03% in 2013.
  • A 5-year view of Curent Deferred Tax Liability shows it stood at $9.2 million in 2010, then advanced by 21.74% to $11.2 million in 2011, then plunged by 38.39% to $6.9 million in 2012, then surged by 142.03% to $16.7 million in 2013, then retreated by 10.18% to $15.0 million in 2014.
  • The last three Curent Deferred Tax Liability figures came in at $15.0 million (Q4 2014), $16.7 million (Q4 2013), and $6.9 million (Q4 2012), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Curent Deferred Tax (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 Bruker 8.89 Bn 8.77 Bn 379.80 Mn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2014 15.00 Mn
Dec 31, 2014 15.00 Mn
Dec 31, 2013 16.70 Mn
Dec 31, 2013 16.70 Mn
Dec 31, 2012 6.90 Mn
Dec 31, 2012 6.90 Mn
Dec 31, 2011 11.20 Mn
Dec 31, 2011 11.20 Mn
Dec 31, 2010 9.20 Mn
Dec 31, 2010 9.20 Mn